Death risk higher with mental illness in drug trials

August 30, 2013
Death risk higher with mental illness in drug trials
Adults with psychiatric illnesses such as schizophrenia, depression, and bipolar disorder who participate in clinical trials of psychopharmacological drugs have a higher mortality risk, in many cases by suicide, according to a study published online Aug. 28 in JAMA Psychiatry.

(HealthDay)—Adults with psychiatric illnesses such as schizophrenia, depression, and bipolar disorder who participate in clinical trials of psychopharmacological drugs have a higher mortality risk, in many cases by suicide, according to a study published online Aug. 28 in JAMA Psychiatry.

Arif Khan, M.D., from the Northwest Clinical Research Center in Bellevue, Washington, and colleagues analyzed for 92,542 patients with from the U.S. Food and Drug Administration Summary Basis of Approval reports for 28 psychopharmacological agents approved between 1990 and 2011.

The researchers found that, compared with the general population, the risk of mortality was 3.8-fold higher in patients with schizophrenia, 3.15-fold higher in patients with depression, and 3.0-fold higher in patients with bipolar disorder. Death was due to suicide in 41.1 percent of 265 cases. Assignment to psychotropic agents rather than placebo did not increase , with the exception of heterocyclic antidepressants.

"These data suggest that increased mortality rates reported in population studies are detectable among adult patients with psychiatric illnesses participating in psychopharmacological trials," Khan and colleagues conclude.

Arif Khan founded Columbia Northwest Pharmaceuticals.

Explore further: Community treatment of psych patients tied to less mortality

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Community treatment of psych patients tied to less mortality

November 13, 2012
(HealthDay)—For patients with psychiatric disorders, community treatment orders correlate with a reduction in mortality, according to research published online Nov. 12 in CMAJ, the journal of the Canadian Medical Association.

Study links mental illness to early death in people with epilepsy

July 22, 2013
People with epilepsy are ten times more likely to die early, before their mid-fifties, compared with the general population, according to a 41 year study in Sweden published today in the Lancet and part-funded by the Wellcome ...

Borderline personality, bipolar disorders have similar unemployment rates

December 11, 2012
Unemployment poses a significant burden on the public no matter what the cause. But for those who have been diagnosed with a psychiatric illness, chronic unemployment is often coupled with significant health care costs. A ...

New patterns found in the genetic relationship of five major psychiatric disorders

August 11, 2013
The largest genome-wide study of its kind has determined how much five major mental illnesses are traceable to the same common inherited genetic variations. Researchers funded in part by the National Institutes of Health ...

Mortality similar for single and multiple primary melanomas

June 24, 2013
(HealthDay)—Mortality is similar for patients with single primary melanomas (SPMs) and multiple primary melanomas (MPMs), but relative mortality is considerably higher for patients with thicker SPMs versus thicker MPMs, ...

Recommended for you

Higher cognitive abilities linked to greater risk of stereotyping

July 24, 2017
People with higher cognitive abilities are more likely to learn and apply social stereotypes, finds a new study. The results, stemming from a series of experiments, show that those with higher cognitive abilities also more ...

Psychologists say our 'attachment style' applies to social networks like Facebook

July 24, 2017
A new investigation appearing this week in the Personality and Social Psychology Bulletin suggests a strong association between a person's attachment style—how avoidant or anxious people are in their close relationships—and ...

World-first ketamine trial shows promise for geriatric depression

July 24, 2017
Australian researchers have completed the world's first randomised control trial (RCT) assessing the efficacy and safety of ketamine as a treatment for depression in elderly patients.

Musicians have high prevalence of eating disorders, study finds

July 24, 2017
They may live for the limelight and the call of their muse, but musicians may also be prone to eating disorders, according to new research.

Neuroticism may postpone death for some

July 24, 2017
Data from a longitudinal study of over 500,000 people in the United Kingdom indicate that having higher levels of the personality trait neuroticism may reduce the risk of death for individuals who report being in fair or ...

Study examines effects of stopping psychiatric medication

July 20, 2017
Despite numerous obstacles and severe withdrawal effects, long-term users of psychiatric drugs can stop taking them if they choose, and mental health care professionals could be more helpful to such individuals, according ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.